Product Introduction

#### 1. Overview

Hepius brand Letrozole, with the commercial name Femara, is a non-steroidal aromatase inhibitor, mainly used to treat breast cancer. Letrozole inhibits aromatase and reduces the production of estrogen, thereby inhibiting the growth of estrogen-dependent breast cancer. As a company focusing on high-quality generic and branded drugs, Hepius's Letrozole products are known for their high efficiency and reliability in the market.

#### 2. Drug classification

Hepius brand Letrozole can be divided into the following categories according to its dosage form, dosage and use:

1. **Oral tablets**

- **Standard dose tablets**: The common dose is 2.5mg, once a day, suitable for most breast cancer patients.

- **Low dose tablets**: The dose is 1.25mg, suitable for patients who are sensitive to standard doses or need to adjust the dose.

2. **Sustained release tablets**

- **Sustained release tablets**: Made through a special process, the drug is slowly released in the body, reducing the frequency of medication and improving patient compliance.

3. **Combined preparations**

- **Combined preparations**: Combined with other anticancer drugs or auxiliary drugs to form a combined preparation for multi-drug combination therapy to enhance efficacy.

#### 3. Advantages

Hepius brand Letrozole has the following significant advantages:

1. **High efficiency**

- Letrozole significantly reduces the level of estrogen in the body by strongly inhibiting aromatase, effectively inhibiting the growth and spread of breast cancer cells.

2. **Selectivity**

- Letrozole selectively inhibits aromatase, does not affect the production of other hormones, and reduces the occurrence of side effects.

3. **Good tolerance**

- Compared with other aromatase inhibitors, Letrozole has fewer side effects, better patient tolerance, and improved quality of life.

4. **Convenience**

- Oral tablet design, easy to take, patients can take the medicine at home, reducing the frequency of hospital visits.

5. **Economical**

- As a generic drug brand, Hepius's Letrozole product is relatively low-priced, reducing the economic burden on patients while ensuring the quality and efficacy of the drug.

6. **Wide range of indications**

- In addition to breast cancer, Letrozole can also be used to treat other estrogen-dependent tumors, as well as ovulation induction therapy in assisted reproductive technology.

#### 4. Clinical application

Hepius brand Letrozole has a wide range of clinical applications, mainly including the following aspects:

1. **Breast cancer treatment**

- **Early breast cancer**: As an adjuvant therapy, it is used for early breast cancer in postmenopausal women to reduce the risk of recurrence.

- **Advanced breast cancer**: It is used for advanced breast cancer in postmenopausal women, especially those with hormone receptor-positive disease, to prolong survival.

2. **Assisted reproductive technology**

- **Ovulation induction therapy**: It is used for ovulation induction therapy in patients with polycystic ovary syndrome (PCOS) to improve pregnancy rate.

3. **Other estrogen-dependent tumors**

- **Endometrial cancer**: used to treat estrogen receptor-positive endometrial cancer and inhibit tumor growth.

#### 5. Precautions

When using Hepius brand Letrozole, please pay attention to the following matters:

1. **Contraindications**

- Patients who are allergic to Letrozole or any of its ingredients are prohibited.

- Pregnant and lactating women are prohibited to avoid adverse effects on the fetus or infant.

2. **Side effects**

- Common side effects include hot flashes, joint pain, fatigue, etc., which are generally mild and can be tolerated by patients.

- Severe side effects such as osteoporosis and cardiovascular events are relatively rare and need to be closely monitored.

3. **Drug interactions**

- Letrozole may interact with certain drugs (such as estrogen preparations, CYP3A4 inhibitors, etc.) and must be used under the guidance of a doctor.

4. **Special populations**

- Patients with impaired liver function need to adjust the dose and monitor liver function regularly.

- Elderly patients do not need to adjust the dose, but need to monitor side effects closely.

#### 6. Conclusion

Hepius brand Letrozole (Femara) is a highly effective and selective aromatase inhibitor, which plays an important role in the treatment of breast cancer and other estrogen-dependent tumors. Its advantages include high efficiency, selectivity, good tolerability, convenience, economy and wide indications. In clinical applications, attention should be paid to contraindications, side effects, drug interactions and use in special populations. Overall, Hepius brand Letrozole provides patients with a reliable treatment option that helps improve treatment efficacy and quality of life.